NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
WednesdaySep 27, 2017 1:00 pm

Zomedica Pharmaceuticals Corp. (ZOMHF) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Zomedica Pharmaceuticals (OTC: ZOMHF) is a veterinary pharmaceutical and health care solutions company creating innovative products for companion animals (canine, feline and equine) by focusing on your needs as a clinical veterinarian. The company is developing a diversified portfolio to include diagnostics, devices, innovative drugs, and drug-delivery technologies. Zomedica’s team is comprised of clinical veterinary professionals with a mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit the company’s website at www.zomedica.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1)…

Continue Reading

WednesdaySep 27, 2017 11:30 am

Rexahn Pharmaceuticals, Inc. (NYSE: RNN) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Rexahn Pharmaceuticals (NYSE: RNN) is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for the treatment of cancer. Rexahn's product candidates target and neutralize specific proteins believed to be involved in the complex biological force that leads to cancer cell growth. The company’s broad oncology pipeline includes three anti-cancer compounds currently in phase II clinical development: Supinoxin™, RX-3117, and Archexin®. Rexahn also has a novel nanopolymer-based drug delivery platform technology that may increase the bio-availability of FDA-approved chemotherapies. For more information, visit the company’s website at www.rexahn.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

Continue Reading

WednesdaySep 27, 2017 11:30 am

Yangtze River Development Limited (NASDAQ: YERR) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Yangtze River Development (NASDAQ: YERR) is primarily engaged in real estate development with a port logistic project located in the middle reaches of the Yangtze River. Wuhan Newport is a large infrastructure development project implemented under China's latest "One Belt One Road" initiative and is strategically positioned in the "Free Trade Zone" of the Wuhan Port, a crucial trading window between China, the Middle East and Europe. Upon project completion, the logistics center will house six operating zones, including port operation area, warehouse and distribution area, cold chain logistics area, rail cargo loading area, exhibition area and residential community. It…

Continue Reading

WednesdaySep 27, 2017 11:00 am

PURE Bioscience, Inc. (PURE) Starts Presentation at the 2017 Disruptive Growth Company Showcase

PURE Bioscience (OTCQB: PURE) develops and commercializes proprietary antimicrobial products primarily in the food safety arena and provides solutions to pathogen and hygienic control. The company’s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. For more information, visit the company’s website at www.purebio.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

Continue Reading

WednesdaySep 27, 2017 11:00 am

Dynex Capital, Inc. (NYSE: DX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Dynex Capital (NYSE: DX) is an internally managed mortgage real estate investment trust (REIT) which invests in mortgage assets on a leveraged basis. The company manages a diversified, high-quality, leveraged fixed-income portfolio. Dynex invests in agency and non-agency RMBS, CMBS, and CMBS IO. The company aims to manage these assets in a way that provides its shareholders with attractive, risk-adjusted returns over the long term. For more information, visit the company’s website at www.dynexcapital.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3)…

Continue Reading

WednesdaySep 27, 2017 10:30 am

Cemtrex, Inc. (NASDAQ: CETX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Cemtrex (NASDAQ: CETX) provides electronic manufacturing services of electric system assemblies, instruments and emission monitors for industrial processes, and industrial air filtration and environmental control systems worldwide. The industrial products & services (IPS) segment provides a range of air filtration and environmental control products to various industrial and manufacturing industries, as well as monitoring instruments, software and systems for measurement of emissions of greenhouse gases, hazardous gases, particulate, and other regulated pollutants used in emissions trading. The electronics manufacturing solutions (EMS) segment provides electronic manufacturing services, including product design and sustaining engineering services, printed circuit board assembly and production, cabling…

Continue Reading

WednesdaySep 27, 2017 10:00 am

VolitionRx Ltd. (NYSE: VNRX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

VolitionRx (NYSE: VNRX) is a multi-national life sciences company engaged in the development of simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition’s products are aimed to diagnose a range of cancers quickly, simply, and accurately to achieve an early diagnosis which could potentially prolong the lives of patients and improve the quality of their lives. Volition's research and development activities are…

Continue Reading

WednesdaySep 27, 2017 10:00 am

ChineseInvestors.com, Inc. (CIIX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

ChineseInvestors.com (OTCQB: CIIX) is a financial information website for Chinese-speaking investors in the United States and China. The company also capitalizes on the growing demand for cannabidiol (CBD)-based nutrition and health products. CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services. For more information, visit the company’s website at www.chineseinvestors.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation…

Continue Reading

WednesdaySep 27, 2017 10:00 am

Power Clouds, Inc. (PWCL) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Power Clouds (OTC: PWCL) is a global renewable energy provider engaged in owning and operating clean energy power plants in multiple countries where the combination of regulatory, economic and environment elements are maximized. The company functions by operating solar parks that connect directly to national power grids rather than residential rooftops. The company’s global focus results in operations that are not limited to any one geography, single commercial model or regulatory influence. For more information, visit the company’s website at www.powercloudsInc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers,…

Continue Reading

WednesdaySep 27, 2017 9:30 am

Heat Biologics, Inc. (NASDAQ: HTBX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Heat Biologics (NASDAQ: HTBX) is a biopharmaceutical company developing novel therapies designed to activate a patient’s immune system against cancer using its CD8+ "Killer" T-cells. The company is currently enrolling patients in its phase 2 clinical trial for non-small cell lung cancer, in combination with Bristol-Myers Squibb's nivolumab (Opdivo®). The company also has numerous pre-clinical programs at various stages of development. For more information, visit the company’s website at www.heatbio.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers